Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.09 0.49%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics P/CF Ratio 2011-2024 | RVNC

Annual P/CF Ratio Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.21 -13 -4.06 -8.27 -8.87 -5.73 -10.5 -8.53 -8.55 -5.03 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.21 -13 -7.47